NanoStreeM: Final outcomes and perspectives – nanomaterials and risk
Here, Dr Dimiter Prodanov from IMEC explains the final outcomes and perspectives of the NanoStreeM project, including comments on nanomaterials and risk.
Simulating ionosphere bubbles in the equatorial ionosphere
J.D. Huba from Syntek Technologies shares his expert thoughts on simulating ionosphere bubbles in the equatorial ionosphere.
Physics in Finland: Open science in the making
Katri Huitu and Kati Lassila-Perini from Helsinki Institute of Physics, Finland, chart open science in the making including a short overview of related accelerator research expertise in Finland.
Robotic manipulation research: From the laboratory to the real world
Here, Professor Kensuke Harada discusses the implementation of robotic manipulation research in the real world.
Research and Innovation in Europe: Pushing science forward after COVID-19
Megan Warrender, Assistant Editor at Open Access Government, discusses research and innovation in Europe, and why in a post COVID-19 world, science is more important than ever.
Chemistry: Nanocellulose filters for water purification
Benjamin S. Hsiao, Distinguished Professor from Stony Brook University details nanocellulose filters for water purification in this fascinating chemistry focus.
Gravitational wave science in Europe: from Virgo to Einstein Telescope
Professor Jo van den Brand at the National Institute for Subatomic Physics (Nikhef) discusses developments in the world of gravitational wave science.
Food safety: Assessing mixtures of endocrine disruptors
Alberto Mantovani from Istituto Superiore di Sanità, Roma, Italy, looks at an aspect of food safety that concerns assessing mixtures of endocrine disruptors.
Open Science in Europe: A challenge to benefit all
Frédérique Vidal, Minister of Higher Education, Research, and Innovation in France, weighs up the benefits and challenges of achieving open science in Europe.
Surface functionalization: A tool for biotechnology and health sectors
Professor Sandra Carvalho, University of Minho, Department of Physics, discusses the emergence of surface functionalization as a strategy in biotech and health.
Extending intellectual frontiers in atmospheric and geospace sciences
Here, Open Access Government probes how the National Science Foundation in the U.S. supports extending intellectual frontiers in the atmospheric and geospace sciences.
The RSIF-PASET Programme: Food security and agribusiness at SACIDS Foundation
Here, Professor Gerald Misinzo and Professor Mark Rweyemamu discuss the potential of the RSIF-PASET Programme.
OPRECOMP: Transprecision computing for energy efficiency
Cristiano Malossi, PhD, Manager AI Automation at IBM Research – Zurich tells us what we need to know about the OPRECOMP project that concerns transprecision computing for energy efficiency.
Indigenous youth resilience: Water protectors
Dr Dawn Martin-Hill and Dr Christine Wekerle from McMaster University highlight Indigenous youth resilience research, including comment on what water teaches us.
“Space 2.0” and the problem of orbital debris
Dr David Carroll from CU Aerospace LLC says that there are advantages to nano-satellites and the Space 2.0 environment, but they exacerbate the problem of orbital debris.
JPND: The largest global collaborative initiative for neurodegenerative disease research
Chairman for the global initiative EU Joint Programme – Neurodegenerative Disease Research (JPND) Professor Philippe Amouyel brings to light their innovative work in neurodegenerative disease research.
Nanotechnology: Modern innovation demands regulatory preparedness in risk governance
Monique Groenewold discusses how modern innovation requires regulatory preparedness in risk governance, especially for nanotechnology.
Future machines to explore new frontiers in particle physics
Jim Siegrist from the Office of Science at the U.S. Department of Energy, charts how future machines will explore new frontiers in particle physics.
Rethinking Type 1 diabetes with a radically new immunotherapy approach
Jean Van Rampelbergh PhD, VP Clinical & Regulatory at Imcyse SA, introduces Imotopes™, the innovative new immunotherapy approach causing scientists to rethink Type 1 diabetes and its treatment.
LRG1: An emerging therapeutic target for the treatment of microvascular dysfunction
John Greenwood PhD and Stephen E. Moss PhD explore the imminent potential of LRG1 as a microvascular dysfunction treatment.
